News
On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), announced a strategic ...
Person-centred care bridges the gap between health systems and human needs, ensuring dignity, equity, and long-term impact in managing chronic and infectious diseases.
The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pharmacokinetics of ...
Metabolic dysfunction affects 1 in 3 Indian adults. Mandatory lifestyle changes, awareness campaigns, and early screening are ...
Many adults have a heart age older than their actual age, raising health risks. Technology now makes it easier to understand ...
A probiotic-fermented stevia extract may fight pancreatic cancer by triggering cancer cell death according to lab studies.
Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated ...
Zenara Pharma Private Limited ("Zenara"), a Biophore company, today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug ...
New insights into how β-cell subtypes influence diabetes risk and how maternal diet, epigenetics, and stem cell therapies may ...
Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio® (inclisiran), enabling its use as monotherapy along with diet and exercise to reduce low ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has submitted a ...
Pregnant women are at increased risk of illness due to infection compared with other adults, so avoiding infection is essential for them. Until January 2025, the CDC stated that a COVID-19 vaccine was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results